You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: January 1, 2026

Claims for Patent: 11,466,271

✉ Email this page to a colleague

Summary for Patent: 11,466,271

Title:	Compositions and methods for the treatment of hemoglobinopathies
Abstract:	The present invention is directed to genome editing systems, reagents and methods for the treatment of hemoglobinopathies.
Inventor(s):	Craig Stephen Mickanin, Christian SCHMEDT, Jennifer SNEAD, Susan Stevenson, Yi Yang
Assignee:	Novartis AG , Novartis Institutes for Biomedical Research Inc , Intellia Therapeutics Inc
Application Number:	US16/484,046

Details for Patent 11,466,271

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Vertex Pharmaceuticals Inc	CASGEVY	exagamglogene autotemcel	Suspension	125787	December 08, 2023	11,466,271	2038-02-05
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,466,271

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2018142364	⤷ Get Started Free
United States of America	2023118337	⤷ Get Started Free
United States of America	2020102561	⤷ Get Started Free
Taiwan	201839136	⤷ Get Started Free
Singapore	11201907056X	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.